Clinical Trial Update: Study to Compare the Efficacy of Pristinamycin (Pyostacine ®) Versus Amoxicillin in the Treatment of Acute Community Acquired Pneumonia [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing pristinamycin (Pyostacine) to amoxicillin for acute community-acquired pneumonia was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia

Drugs mentioned

• AMOXICILLIN (AMOXICILLIN)
• Pristinamycin (Pyostacine) (pristinamycin)

Snippet

Sponsor: Sanofi | Conditions: Pneumonia | Phase 4 | Status: TERMINATED